Table 2.
ASCO Recommendations for Breast Surveillance, and Verbal and Written Comments*
Test | Frequency | Comments to Discuss With the Patient (a script) |
---|---|---|
Recommended | My professional society has made recommendations on what should be generally recommended for women in your situation; this group wrestled with the issues for 18 months and will update these yearly or whenever new information becomes available | |
History/eliciting of symptoms and physical examination | Every 3 to 6 months for 3 years, then every 6 to 12 months for 2 years, then annually | Careful history and examination, like we just did, should be done every 3 to 6 months; if you have concerns, write them down, and call me in between visits; women find more than three quarters of all recurrences in between physician visits, so call me if you suspect something |
BSE | Monthly | BSE is recommended; do it monthly (congratulate her if she is, and urge her to do it if not); would you like instructions? |
Mammography | Annually | Mammography is recommended; get it done each year at the same place (I have a table on my chart to remind me about this, pelvic and rectal examinations, colonoscopy, and other preventive health care procedures) |
Pelvic examination | Annually | Pelvic examinations and PAP smears should be done yearly because you are receiving tamoxifen (or not); endometrial biopsies are not needed because the risk of uterine cancer is so low—only one in 100—but report any abnormal bleeding |
Patient education regarding symptoms of recurrence | NA | There are specific things I want you to watch for, the most common spots of recurrence; call me if you notice these things (point to the area in the guidelines that has these bullet points):
|
Coordination of care | NA | You only need to see one physician, not three or four, but it needs to be someone experienced in breast cancer examinations; I can alternate with your surgeon, Dr X, and your radiotherapist, Dr Y, or you can choose one person, but you need to see someone every 3 to 6 months for the first 3 years; it can be your primary care physician, Dr Z |
Not recommended | Our professional society has recommended that some tests not be done, because it could not find evidence that the tests were helpful; I do these tests, but only to diagnose something, not for screening; we should concentrate on making sure that you undergo the tests that we know make a difference (point to the list of tests not recommended) | |
CBC and chemistry studies | These never detect an early or curable recurrence | |
Chest films | Chest x-ray rarely if ever finds an early or curable recurrence | |
Bone scan | Same for the bone scan; it detects arthritis and stress fractures but not curable disease; it is more important that you report any new bone pain | |
Ultrasound of the liver; CT of the chest, abdomen, or pelvis; PET scans | Same for liver ultrasound and CT scans; a large trial of > 1,000 women in Italy showed no benefit to doing yearly liver ultrasounds and bone scans for routine surveillance, so they are not recommended; they find too many nuisances, and do not detect early curable cancer | |
Tumor markers CA 15-3, CA 27.29, CEA | I wish I had a perfect blood test that would tell me whether you have breast cancer cells left; every biotech company would, too; but none of the current tests are good enough to do routinely; the ASCO expert panel found that there was too much of a problem of missed cancer and falsely showing cancer was there, and it could not find any evidence that finding the cancer a few weeks or months earlier would lead to better treatment | |
This is an area where the tests are getting better; at the present time, I do not order any of these tests, but if new evidence shows that these tests are helpful, ASCO will review the evidence when it comes out and change the guideline; for now, we should concentrate on doing the tests we know make a difference and not doing others |
Abbreviations: ASCO, American Society of Clinical Oncology; BSE, breast self-examination; CA, cancer antigen; CBC, complete blood count; CEA, carcinoembryonic antigen; CT, computed tomography; NA, not applicable; PAP, Papanicolaou; PET, positron emission tomography.
I write directly on a printed copy of the surveillance guidelines and fax a copy to the primary care physician.